Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2014 1
2020 2
2021 4
2022 4
2023 6
2024 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Women in the European Virus Bioinformatics Center.
Hufsky F, Abecasis A, Agudelo-Romero P, Bletsa M, Brown K, Claus C, Deinhardt-Emmer S, Deng L, Friedel CC, Gismondi MI, Kostaki EG, Kühnert D, Kulkarni-Kale U, Metzner KJ, Meyer IM, Miozzi L, Nishimura L, Paraskevopoulou S, Pérez-Cataluña A, Rahlff J, Thomson E, Tumescheit C, van der Hoek L, Van Espen L, Vandamme AM, Zaheri M, Zuckerman N, Marz M. Hufsky F, et al. Among authors: zaheri m. Viruses. 2022 Jul 12;14(7):1522. doi: 10.3390/v14071522. Viruses. 2022. PMID: 35891501 Free PMC article.
Assessing immunogenicity barriers of the HIV-1 envelope trimer.
Maliqi L, Friedrich N, Glögl M, Schmutz S, Schmidt D, Rusert P, Schanz M, Zaheri M, Pasin C, Niklaus C, Foulkes C, Reinberg T, Dreier B, Abela I, Peterhoff D, Hauser A, Kouyos RD, Günthard HF, van Gils MJ, Sanders RW, Wagner R, Plückthun A, Trkola A. Maliqi L, et al. Among authors: zaheri m. NPJ Vaccines. 2023 Sep 30;8(1):148. doi: 10.1038/s41541-023-00746-3. NPJ Vaccines. 2023. PMID: 37777519 Free PMC article.
Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data.
Nadeau SA, Vaughan TG, Beckmann C, Topolsky I, Chen C, Hodcroft E, Schär T, Nissen I, Santacroce N, Burcklen E, Ferreira P, Jablonski KP, Posada-Céspedes S, Capece V, Seidel S, Santamaria de Souza N, Martinez-Gomez JM, Cheng P, Bosshard PP, Levesque MP, Kufner V, Schmutz S, Zaheri M, Huber M, Trkola A, Cordey S, Laubscher F, Gonçalves AR, Aeby S, Pillonel T, Jacot D, Bertelli C, Greub G, Leuzinger K, Stange M, Mari A, Roloff T, Seth-Smith H, Hirsch HH, Egli A, Redondo M, Kobel O, Noppen C, du Plessis L, Beerenwinkel N, Neher RA, Beisel C, Stadler T. Nadeau SA, et al. Among authors: zaheri m. Sci Transl Med. 2023 Jan 25;15(680):eabn7979. doi: 10.1126/scitranslmed.abn7979. Epub 2023 Jan 25. Sci Transl Med. 2023. PMID: 36346321 Free PMC article.
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1.
Balakrishna S, Loosli T, Zaheri M, Frischknecht P, Huber M, Kusejko K, Yerly S, Leuzinger K, Perreau M, Ramette A, Wymant C, Fraser C, Kellam P, Gall A, Hirsch HH, Stoeckle M, Rauch A, Cavassini M, Bernasconi E, Notter J, Calmy A, Günthard HF, Metzner KJ, Kouyos RD. Balakrishna S, et al. Among authors: zaheri m. J Antimicrob Chemother. 2023 Mar 2;78(3):656-664. doi: 10.1093/jac/dkac430. J Antimicrob Chemother. 2023. PMID: 36738248 Free article.
Nosocomial COVID-19 Incidence and Secondary Attack Rates among Patients of Tertiary Care Center, Zurich, Switzerland.
Wolfensberger A, Kufner V, Zaheri M, Zeeb M, Nortes I, Schreiber PW, Vazquez M, Schärer V, Scheier T, Schmutz S, Probst E, Saleschus D, Huber M, Rampini SK, Zingg W. Wolfensberger A, et al. Among authors: zaheri m. Emerg Infect Dis. 2022 Oct;28(10):2087-2090. doi: 10.3201/eid2810.220321. Epub 2022 Sep 1. Emerg Infect Dis. 2022. PMID: 36048771 Free PMC article.
External Quality Assessment of SARS-CoV-2 Sequencing: an ESGMD-SSM Pilot Trial across 15 European Laboratories.
Wegner F, Roloff T, Huber M, Cordey S, Ramette A, Gerth Y, Bertelli C, Stange M, Seth-Smith HMB, Mari A, Leuzinger K, Cerutti L, Harshman K, Xenarios I, Le Mercier P, Bittel P, Neuenschwander S, Opota O, Fuchs J, Panning M, Michel C, Hallin M, Demuyser T, De Mendonca R, Savelkoul P, Dingemans J, van der Veer B, Boers SA, Claas ECJ, Coolen JPM, Melchers WJG, Gunell M, Kallonen T, Vuorinen T, Hakanen AJ, Bernhoff E, Hetland MAK, Golan Berman H, Adar S, Moran-Gilad J, Wolf DG, Leib SL, Nolte O, Kaiser L, Schmutz S, Kufner V, Zaheri M, Trkola A, Aamot HV, Hirsch HH, Greub G, Egli A. Wegner F, et al. Among authors: zaheri m. J Clin Microbiol. 2022 Jan 19;60(1):e0169821. doi: 10.1128/JCM.01698-21. Epub 2021 Nov 10. J Clin Microbiol. 2022. PMID: 34757834 Free PMC article.
Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response.
Marconato M, Abela IA, Hauser A, Schwarzmüller M, Katzensteiner R, Braun DL, Epp S, Audigé A, Weber J, Rusert P, Schindler E, Pasin C, West E, Böni J, Kufner V, Huber M, Zaheri M, Schmutz S, Frey BM, Kouyos RD, Günthard HF, Manz MG, Trkola A. Marconato M, et al. Among authors: zaheri m. J Clin Invest. 2022 Jun 15;132(12):e158190. doi: 10.1172/JCI158190. J Clin Invest. 2022. PMID: 35482408 Free PMC article. Clinical Trial.
Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks.
Jörimann L, Tschumi J, Zeeb M, Leemann C, Schenkel CD, Neumann K, Chaudron SE, Zaheri M, Frischknecht P, Neuner-Jehle N, Kuster H, Braun DL, Grube C, Kouyos R, Metzner KJ, Günthard HF; Swiss HIV Cohort Study (SHCS). Jörimann L, et al. Among authors: zaheri m. J Infect Dis. 2023 Oct 3;228(7):907-918. doi: 10.1093/infdis/jiad292. J Infect Dis. 2023. PMID: 37498738 Free PMC article.
19 results